Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Iams

Showing results (261-270 of 282) with videos related to

Pageof 29
Sort By:
American Journal of Obstetrics and Gynecology|September 1, 2009
The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnanciesCynthia Gyamfi, Amanda L Horton, Valerija Momirova, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 10, 2010
Absence of mitochondrial progesterone receptor polymorphisms in women with spontaneous preterm birthTracy A Manuck, Thomas M Price, Elizabeth Thom, et al.
American Journal of Perinatology|April 17, 2020
Maternal and Neonatal Outcomes Associated with Amniotomy among Nulliparous Women Undergoing Labor Induction at TermAshley N Battarbee, Grecio Sandoval, William A Grobman, et al.
American Journal of Obstetrics and Gynecology|May 6, 2008
Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placeboMark A Klebanoff, Paul J Meis, Mitchell P Dombrowski, et al.
Obstetrics and Gynecology|September 2, 2005
Does progesterone treatment influence risk factors for recurrent preterm delivery?Paul J Meis, Mark Klebanoff, Mitchell P Dombrowski, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm deliveryBaha Sibai, Paul J Meis, Mark Klebanoff, et al.
Journal of the Academy of Nutrition and Dietetics|March 22, 2017
Racial or Ethnic and Socioeconomic Inequalities in Adherence to National Dietary Guidance in a Large Cohort of US Pregnant WomenLisa M Bodnar, Hyagriv N Simhan, Corette B Parker, et al.
JAMA|March 15, 2017
Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous WomenM Sean Esplin, Michal A Elovitz, Jay D Iams, et al.
The New England Journal of Medicine|June 13, 2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproatePaul J Meis, Mark Klebanoff, Elizabeth Thom, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous deliveryCatherine Y Spong, Paul J Meis, Elizabeth A Thom, et al.
Pageof 29

Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
American Journal of Obstetrics and Gynecology|September 1, 2009
The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnanciesCynthia Gyamfi, Amanda L Horton, Valerija Momirova, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 10, 2010
Absence of mitochondrial progesterone receptor polymorphisms in women with spontaneous preterm birthTracy A Manuck, Thomas M Price, Elizabeth Thom, et al.
American Journal of Perinatology|April 17, 2020
Maternal and Neonatal Outcomes Associated with Amniotomy among Nulliparous Women Undergoing Labor Induction at TermAshley N Battarbee, Grecio Sandoval, William A Grobman, et al.
American Journal of Obstetrics and Gynecology|May 6, 2008
Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placeboMark A Klebanoff, Paul J Meis, Mitchell P Dombrowski, et al.
Obstetrics and Gynecology|September 2, 2005
Does progesterone treatment influence risk factors for recurrent preterm delivery?Paul J Meis, Mark Klebanoff, Mitchell P Dombrowski, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm deliveryBaha Sibai, Paul J Meis, Mark Klebanoff, et al.
Journal of the Academy of Nutrition and Dietetics|March 22, 2017
Racial or Ethnic and Socioeconomic Inequalities in Adherence to National Dietary Guidance in a Large Cohort of US Pregnant WomenLisa M Bodnar, Hyagriv N Simhan, Corette B Parker, et al.
JAMA|March 15, 2017
Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous WomenM Sean Esplin, Michal A Elovitz, Jay D Iams, et al.
The New England Journal of Medicine|June 13, 2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproatePaul J Meis, Mark Klebanoff, Elizabeth Thom, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous deliveryCatherine Y Spong, Paul J Meis, Elizabeth A Thom, et al.
Pageof 29